-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Edited by Yimaitong, please do not reprint without authorization.
Guide: This article summarizes the guidelines/consensus/expert interpretations of endocrinology diseases released in February and March 2021 for everyone to read and download.
Interpretation of the "2021 American Diabetes Association Diabetes Medical Diagnosis and Treatment Standards" With the continuous emergence of new technologies, new therapies and related evidence-based evidence, the field of diabetes management has changed rapidly in recent years.
Since its first release in 1989, the "Standards for Diabetes Medical Diagnosis and Treatment" formulated by the American Diabetes Association (ADA) covers the latest changes in diabetes diagnosis and treatment, and has become one of the authoritative guidelines for clinical practice of diabetes management.
Recently, the ADA updated the guidelines based on the latest evidence-based evidence, and published the "2021 ADA Diabetes Medical Diagnosis and Treatment Standards" in the Diabetes Care supplement, which aims to provide clinicians, researchers and patients with diabetes management elements and treatment goals And evaluation tools for the quality of diagnosis and treatment.
This article interprets the hot issues and important updates.
Download link: http://guide.
medlive.
cn/guidelinesub/8194 ATA Guideline 2021: Management of Patients with Undifferentiated Thyroid Cancer In March 2021, the American Thyroid Association (ATA) released related information on the “Management of Patients with Undifferentiated Thyroid Cancer” guide.
Undifferentiated thyroid cancer is a rare but high fatality thyroid cancer.
This article mainly provides guidance and recommendations for the management of patients with undifferentiated thyroid cancer.
The content involves diagnosis, initial evaluation, treatment methods and monitoring, etc.
It contains a total of 31 recommendations and 16 best practice statements.Download link: http://guide.
medlive.
cn/guideline/22913 2021AACE/AHNS Consensus Statement: Children's Benign and Malignant Thyroid Surgery In March 2021, the American Academy of Clinical Endocrinologists (AACE) and the American Head and Neck Society (AHNS) jointly issued Consensus Statement on Children's Benign and Malignant Thyroid Surgery.
The main content involves the surgical basis of pediatric thyroid surgery, complex surgical problems unique to children, and future work.
Download link: http://guide.
medlive.
cn/guideline/22949 2021 Japanese Thyroid Association Opinion: Management of Adult Low-risk Papillary Thyroid Microcarcinoma (T1aN0M0) Patients In March 2021, the Japanese Thyroid Association (JTA) issued Opinions on the management of adults with low-risk papillary thyroid microcarcinoma (T1aN0M0).
The incidence of thyroid cancer is on the rise worldwide.
This article presents evidence of the increase in the incidence of papillary thyroid microcarcinoma and provides guidance for the management of such patients.
Download link: http://guide.
medlive.
cn/guideline/22930 Chinese expert consensus on the diagnosis and treatment of Klinefelter syndrome Klinefelter syndrome (Klinefelter syndrome, referred to as Klinefelter syndrome) is the most common in men Sex chromosome abnormalities are also the most common cause of male primary hypogonadism.
In order to standardize the diagnosis and treatment of Klinefelter's syndrome, experts from the Gonadology Group of the Endocrinology Branch of the Chinese Medical Association organized a special discussion and formulated this consensus for clinical reference.
Download link: http://guide.
medlive.
cn/guideline/22855 Type 2 diabetes cardiovascular risk assessment and choice of hypoglycemic drugs for the prevention and treatment of cardiovascular disease-interpretation of "2019ESC/EASD Guidelines for Diabetes, Prediabetes and Cardiovascular Diseases" In August 2019, the European Society of Cardiology (ESC) and the European Society for the Study of Diabetes (EASD) issued the third edition of the Cardiovascular Disease (CVD) Prevention and Treatment Guidelines for people with diabetes (DM) and pre-DM.Although the time interval is not long since the previous edition was released in 2013, there have been endless researches on cardiovascular events in type 2 diabetes (T2D) in recent years, and there is definite evidence that some hypoglycemic drugs have cardiovascular benefits other than hypoglycemic drugs.
Therefore, it is worth promoting and applying these research results to clinical practice as soon as possible.
Due to the large content of this edition of the guide, this article focuses on sharing the relevant parts of T2D cardiovascular risk assessment and the selection of hypoglycemic drugs for the prevention and treatment of CVD, which are closely related to endocrinologists.
Download link: http://guide.
medlive.
cn/guidelinesub/8167 2021 Asian expert advice: use sodium-glucose cotransporter 2 inhibitors in Asian patients with type 2 diabetes and kidney disease to release early release of type 2 diabetes and high incidence of comorbidities The higher the risk of diabetic nephropathy (DKD) and the risk of rapid progression in Asian populations.
In addition to inhibitors of the renin-angiotensin system, sodium-glucose cotransporter 2 inhibitors have also been shown to delay the progression of DKD.
This article mainly relates to the application of sodium-glucose cotransporter 2 inhibitors in Asian patients with type 2 diabetes and kidney disease, and points out that SGLT-2 inhibitors can delay the disease progression of Asian DKD patients and protect the renal function of patients at high risk of kidney disease.
Download link: http://guide.
medlive.
cn/guideline/22787 Introduction of the 2021 "Guidelines for Diagnosis and Treatment of Diabetes in Pregnancy" by the American Diabetes Association In December 2020, the American Diabetes Association (ADA) updated and released the latest evidence-based medical evidence 2021 "Guidelines for Diagnosis and Treatment of Diabetes".
The guidelines are published in the Diabetes Care magazine and include guidelines for the diagnosis and treatment of diabetes mellitus in pregnancy.
Compared with the guidelines published in 2020, the guidelines of 2021 on the management of pregnancy complicated with diabetes [pre-pregnancy type 1 diabetes (T1DM) and type 2 diabetes (T2DM)], preeclampsia and aspirin, drug use during pregnancy, and postpartum health care and follow-up Part of the content has been updated and supplemented.
Regarding pre-pregnancy counseling and health care, blood glucose control goals during pregnancy, and gestational diabetes (GDM) management, the 2021 guidelines are basically consistent with the 2020 guidelines.
This article introduces the updated content of gestational diabetes in the 2021 guideline compared with 2020, in order to provide a reference for clinical practice.
Download link: http://guide.
medlive.
cn/guidelinesub/8197 Expert consensus on adult perioperative blood glucose monitoring.
Perioperative blood glucose management is very important.
Accurate, fast and convenient blood glucose monitoring methods and practical monitoring programs are the prerequisites for effective management of perioperative blood glucose.
In order to obtain satisfactory blood glucose management for patients during perioperative period, it is very important to regulate the scope of blood glucose monitoring program during operation.
Based on the latest evidence-based medical evidence and the clinical practice of DM prevention and treatment in my country, the Nursing Branch of the Chinese Research Hospital Association cooperates with the Beijing Society of Perioperative Medicine, the Diabetes Committee of the Chinese Research Hospital Association, the Diabetes Nursing Committee of the Chinese Nursing Society, and China Nursing The Society of Surgical Nursing Special Committee organizes multidisciplinary medical experts to compile this consensus, hoping to provide clinical guidance and practical adult perioperative blood glucose monitoring programs.
Recommended reading: What should be paid attention to in blood glucose monitoring during perioperative period? The latest expert consensus is here! Download link: http://guide.
medlive.
cn/guideline/22748 Hyperthyroidism Syndrome Combined Diagnosis and Treatment Guidelines Hyperactivity is a group of clinical syndromes with main manifestations, and Graves disease is the most common type.
This guide is organized and compiled by the Endocrinology and Metabolic Diseases Professional Committee of the Chinese Medical Physician Association Branch of Integrative Medicine Physicians.
It is for clinicians to use as a reference when treating Graves' disease with a combination of disease and syndrome.
Hyperthyroidism caused by other causes can also refer to this guide for diagnosis and treatment.
Download link: http://guide.
medlive.
cn/guideline/22696
Guide: This article summarizes the guidelines/consensus/expert interpretations of endocrinology diseases released in February and March 2021 for everyone to read and download.
Interpretation of the "2021 American Diabetes Association Diabetes Medical Diagnosis and Treatment Standards" With the continuous emergence of new technologies, new therapies and related evidence-based evidence, the field of diabetes management has changed rapidly in recent years.
Since its first release in 1989, the "Standards for Diabetes Medical Diagnosis and Treatment" formulated by the American Diabetes Association (ADA) covers the latest changes in diabetes diagnosis and treatment, and has become one of the authoritative guidelines for clinical practice of diabetes management.
Recently, the ADA updated the guidelines based on the latest evidence-based evidence, and published the "2021 ADA Diabetes Medical Diagnosis and Treatment Standards" in the Diabetes Care supplement, which aims to provide clinicians, researchers and patients with diabetes management elements and treatment goals And evaluation tools for the quality of diagnosis and treatment.
This article interprets the hot issues and important updates.
Download link: http://guide.
medlive.
cn/guidelinesub/8194 ATA Guideline 2021: Management of Patients with Undifferentiated Thyroid Cancer In March 2021, the American Thyroid Association (ATA) released related information on the “Management of Patients with Undifferentiated Thyroid Cancer” guide.
Undifferentiated thyroid cancer is a rare but high fatality thyroid cancer.
This article mainly provides guidance and recommendations for the management of patients with undifferentiated thyroid cancer.
The content involves diagnosis, initial evaluation, treatment methods and monitoring, etc.
It contains a total of 31 recommendations and 16 best practice statements.Download link: http://guide.
medlive.
cn/guideline/22913 2021AACE/AHNS Consensus Statement: Children's Benign and Malignant Thyroid Surgery In March 2021, the American Academy of Clinical Endocrinologists (AACE) and the American Head and Neck Society (AHNS) jointly issued Consensus Statement on Children's Benign and Malignant Thyroid Surgery.
The main content involves the surgical basis of pediatric thyroid surgery, complex surgical problems unique to children, and future work.
Download link: http://guide.
medlive.
cn/guideline/22949 2021 Japanese Thyroid Association Opinion: Management of Adult Low-risk Papillary Thyroid Microcarcinoma (T1aN0M0) Patients In March 2021, the Japanese Thyroid Association (JTA) issued Opinions on the management of adults with low-risk papillary thyroid microcarcinoma (T1aN0M0).
The incidence of thyroid cancer is on the rise worldwide.
This article presents evidence of the increase in the incidence of papillary thyroid microcarcinoma and provides guidance for the management of such patients.
Download link: http://guide.
medlive.
cn/guideline/22930 Chinese expert consensus on the diagnosis and treatment of Klinefelter syndrome Klinefelter syndrome (Klinefelter syndrome, referred to as Klinefelter syndrome) is the most common in men Sex chromosome abnormalities are also the most common cause of male primary hypogonadism.
In order to standardize the diagnosis and treatment of Klinefelter's syndrome, experts from the Gonadology Group of the Endocrinology Branch of the Chinese Medical Association organized a special discussion and formulated this consensus for clinical reference.
Download link: http://guide.
medlive.
cn/guideline/22855 Type 2 diabetes cardiovascular risk assessment and choice of hypoglycemic drugs for the prevention and treatment of cardiovascular disease-interpretation of "2019ESC/EASD Guidelines for Diabetes, Prediabetes and Cardiovascular Diseases" In August 2019, the European Society of Cardiology (ESC) and the European Society for the Study of Diabetes (EASD) issued the third edition of the Cardiovascular Disease (CVD) Prevention and Treatment Guidelines for people with diabetes (DM) and pre-DM.Although the time interval is not long since the previous edition was released in 2013, there have been endless researches on cardiovascular events in type 2 diabetes (T2D) in recent years, and there is definite evidence that some hypoglycemic drugs have cardiovascular benefits other than hypoglycemic drugs.
Therefore, it is worth promoting and applying these research results to clinical practice as soon as possible.
Due to the large content of this edition of the guide, this article focuses on sharing the relevant parts of T2D cardiovascular risk assessment and the selection of hypoglycemic drugs for the prevention and treatment of CVD, which are closely related to endocrinologists.
Download link: http://guide.
medlive.
cn/guidelinesub/8167 2021 Asian expert advice: use sodium-glucose cotransporter 2 inhibitors in Asian patients with type 2 diabetes and kidney disease to release early release of type 2 diabetes and high incidence of comorbidities The higher the risk of diabetic nephropathy (DKD) and the risk of rapid progression in Asian populations.
In addition to inhibitors of the renin-angiotensin system, sodium-glucose cotransporter 2 inhibitors have also been shown to delay the progression of DKD.
This article mainly relates to the application of sodium-glucose cotransporter 2 inhibitors in Asian patients with type 2 diabetes and kidney disease, and points out that SGLT-2 inhibitors can delay the disease progression of Asian DKD patients and protect the renal function of patients at high risk of kidney disease.
Download link: http://guide.
medlive.
cn/guideline/22787 Introduction of the 2021 "Guidelines for Diagnosis and Treatment of Diabetes in Pregnancy" by the American Diabetes Association In December 2020, the American Diabetes Association (ADA) updated and released the latest evidence-based medical evidence 2021 "Guidelines for Diagnosis and Treatment of Diabetes".
The guidelines are published in the Diabetes Care magazine and include guidelines for the diagnosis and treatment of diabetes mellitus in pregnancy.
Compared with the guidelines published in 2020, the guidelines of 2021 on the management of pregnancy complicated with diabetes [pre-pregnancy type 1 diabetes (T1DM) and type 2 diabetes (T2DM)], preeclampsia and aspirin, drug use during pregnancy, and postpartum health care and follow-up Part of the content has been updated and supplemented.
Regarding pre-pregnancy counseling and health care, blood glucose control goals during pregnancy, and gestational diabetes (GDM) management, the 2021 guidelines are basically consistent with the 2020 guidelines.
This article introduces the updated content of gestational diabetes in the 2021 guideline compared with 2020, in order to provide a reference for clinical practice.
Download link: http://guide.
medlive.
cn/guidelinesub/8197 Expert consensus on adult perioperative blood glucose monitoring.
Perioperative blood glucose management is very important.
Accurate, fast and convenient blood glucose monitoring methods and practical monitoring programs are the prerequisites for effective management of perioperative blood glucose.
In order to obtain satisfactory blood glucose management for patients during perioperative period, it is very important to regulate the scope of blood glucose monitoring program during operation.
Based on the latest evidence-based medical evidence and the clinical practice of DM prevention and treatment in my country, the Nursing Branch of the Chinese Research Hospital Association cooperates with the Beijing Society of Perioperative Medicine, the Diabetes Committee of the Chinese Research Hospital Association, the Diabetes Nursing Committee of the Chinese Nursing Society, and China Nursing The Society of Surgical Nursing Special Committee organizes multidisciplinary medical experts to compile this consensus, hoping to provide clinical guidance and practical adult perioperative blood glucose monitoring programs.
Recommended reading: What should be paid attention to in blood glucose monitoring during perioperative period? The latest expert consensus is here! Download link: http://guide.
medlive.
cn/guideline/22748 Hyperthyroidism Syndrome Combined Diagnosis and Treatment Guidelines Hyperactivity is a group of clinical syndromes with main manifestations, and Graves disease is the most common type.
This guide is organized and compiled by the Endocrinology and Metabolic Diseases Professional Committee of the Chinese Medical Physician Association Branch of Integrative Medicine Physicians.
It is for clinicians to use as a reference when treating Graves' disease with a combination of disease and syndrome.
Hyperthyroidism caused by other causes can also refer to this guide for diagnosis and treatment.
Download link: http://guide.
medlive.
cn/guideline/22696
